Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
142 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07512505 | Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor(VITAL-PC) | recruiting | — | 120 | Our Lady's Hospice and Care ServicesOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT07426809 | Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study).(MOZART) | recruiting | N/A | 314 | Royal College of Surgeons, IrelandOTHER |
| 1 |
| Apr 3, 2026 |
| clinicaltrials |
| NCT07503704 | A Prospective Study of the Genomic Landscape of Central Nervous System Disease Secondary to Breast Cancer Utilising Cell-free DNA Derived From Cerebrospinal Fluid (CSF)(PRIMROSE) | recruiting | — | 69 | Royal College of Surgeons, IrelandOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT07503717 | SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveillance(SURVEY-CNS) | recruiting | N/A | 69 | Royal College of Surgeons, IrelandOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT04109079 | Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy(ATNEC) | recruiting | N/A | 1,900 | University Hospitals of Derby and Burton NHS Foundation TrustOTHER | 2 | Mar 30, 2026 | clinicaltrials |
| NCT06093672 | Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera(GIV-IN-PV) | recruiting | Phase 3 | 220 | ItalfarmacoINDUSTRY | 16 | Mar 25, 2026 | clinicaltrials |
| NCT06932562 | A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant | recruiting | Phase 3 | 1,000 | European Myeloma Network B.V.NETWORK | 18 | Mar 25, 2026 | clinicaltrials |
| NCT05866757 | Discontinuation Study | recruiting | N/A | 70 | University College CorkOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06546631 | Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients(Improve TMZ) | recruiting | — | 55 | University College CorkOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06709651 | Microbiome Immunotherapy Neoadjuvant Assessment(MINA) | recruiting | — | 30 | University College CorkOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT07443579 | Optimal Mammography View Sequencing in Women With a History of Breast Cancer Undergoing Surveillance Mammography(MammoView) | recruiting | N/A | 400 | Royal College of Surgeons, IrelandOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT06523374 | A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer(Endeavor-1) | recruiting | N/A | 50 | University Hospital, AntwerpOTHER | 6 | Feb 24, 2026 | clinicaltrials |
| NCT07426835 | The PHARO Trial: The Incidence of Para-conduit Hernia With Closure of Hiatus Versus the Standard Approach in Robotic Oesophagectomy - A Randomised Controlled Pilot Trial(PHARO) | recruiting | N/A | 40 | Royal College of Surgeons, IrelandOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT07426848 | OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients(OTSMILE) | recruiting | N/A | 96 | Royal College of Surgeons, IrelandOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT07426861 | Pre-Operative Nurse-Led Education With Direct Physiotherapy Referral to Reduce Post-Prostatectomy Incontinence(PRO-ACT) | recruiting | N/A | 80 | Royal College of Surgeons, IrelandOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT07425002 | Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer (PRISM)(PRISM) | recruiting | N/A | 1,600 | Cancer Trials IrelandNETWORK | 1 | Feb 20, 2026 | clinicaltrials |
| NCT06690775 | CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. | recruiting | Phase 2 | 230 | TORL Biotherapeutics, LLCINDUSTRY | 12 | Dec 23, 2025 | clinicaltrials |
| NCT01840293 | Breast Cancer Proteomics and Molecular Heterogeneity | recruiting | — | 1,780 | Cancer Trials IrelandNETWORK | 1 | Dec 19, 2025 | clinicaltrials |
| NCT06237803 | European Myeloma Network (EMN) Sample Project(EMN36) | recruiting | — | 6,000 | European Myeloma Network B.V.NETWORK | 10 | Dec 3, 2025 | clinicaltrials |
| NCT05658640 | HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies(HEM-iSMART D) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 15 | Sep 16, 2025 | clinicaltrials |
| NCT05745714 | HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies(HEM-iSMART C) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 14 | Sep 16, 2025 | clinicaltrials |
| NCT05751044 | HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies(HEM-iSMART B) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 14 | Sep 16, 2025 | clinicaltrials |
| NCT07075016 | Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy(EVOLVE 1) | recruiting | Phase 3 | 227 | Stichting Hemato-Oncologie voor Volwassenen NederlandOTHER | 16 | Aug 19, 2025 | clinicaltrials |
| NCT07099027 | The Lung Health Check Pilot | recruiting | N/A | 2,183 | Royal College of Surgeons, IrelandOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT05086692 | A Beta-only IL-2 ImmunoTherapY Study(ABILITY-1) | recruiting | Phase 1 / Phase 2 | 115 | Medicenna Therapeutics, Inc.INDUSTRY | 7 | Jul 9, 2025 | clinicaltrials |
| NCT06149546 | Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial)(FEED) | recruiting | N/A | 70 | Cancer Trials IrelandNETWORK | 1 | Jul 8, 2025 | clinicaltrials |
| NCT05871996 | Palliative Care and Oncology Survey on Terminology(POST) | recruiting | — | 1,532 | Our Lady's Hospice and Care ServicesOTHER | 2 | Jun 27, 2025 | clinicaltrials |
| NCT04375904 | 'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)(SOURCE Lung) | recruiting | Phase 2 | 68 | Cancer Trials IrelandNETWORK | 1 | May 2, 2025 | clinicaltrials |
| NCT06078813 | Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases(Spine-SABR) | recruiting | Phase 1 / Phase 2 | 126 | Cancer Trials IrelandNETWORK | 1 | Apr 30, 2025 | clinicaltrials |
| NCT03818503 | E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe(E²-RADIatE) | recruiting | — | 2,000 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Mar 21, 2025 | clinicaltrials |
| NCT04460352 | Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer(NEEDS) | recruiting | Phase 3 | 1,020 | Karolinska University HospitalOTHER | 5 | Mar 6, 2025 | clinicaltrials |
| NCT05793554 | CLASSICA: Validating AI in Classifying Cancer in Real-Time Surgery | recruiting | — | 600 | Mater Misericordiae University HospitalOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06723899 | Testing the Effectiveness of a Work Rehabilitation Intervention for Women with Breast Cancer(CanWork) | recruiting | N/A | 248 | University of Dublin, Trinity CollegeOTHER | 1 | Dec 17, 2024 | clinicaltrials |
| NCT03860883 | Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma(MelMarT-II) | recruiting | N/A | 2,998 | Melanoma and Skin Cancer Trials LimitedOTHER | 10 | Nov 27, 2024 | clinicaltrials |
| NCT05613023 | A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT(PACE-NODES) | recruiting | Phase 3 | 1,128 | Institute of Cancer Research, United KingdomOTHER | 3 | Sep 19, 2024 | clinicaltrials |
| NCT06287294 | An Investigation Into Taste Problems Associated With Xerostomia in Patients With Advanced Cancer | recruiting | — | 120 | Our Lady's Hospice and Care ServicesOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06588933 | TQ-PAL Development and Validation | recruiting | — | 200 | Prof Andrew DaviesOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT04625907 | FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma(FaR-RMS) | recruiting | Phase 1 / Phase 2 | 1,672 | University of BirminghamOTHER | 20 | May 23, 2024 | clinicaltrials |
| NCT04793919 | Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia | recruiting | Phase 2 | 89 | Associazione Italiana Ematologia Oncologia PediatricaOTHER | 12 | Apr 15, 2024 | clinicaltrials |
| NCT06275204 | H. Pylori Screen-and-treat Study in a Population of Young Adults | recruiting | — | 6,800 | University of LatviaOTHER | 6 | Mar 5, 2024 | clinicaltrials |
| NCT03997643 | Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial | recruiting | Phase 2 | 90 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 4 | Aug 3, 2023 | clinicaltrials |
| NCT01704716 | High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) | recruiting | Phase 3 | 3,300 | St. Anna KinderkrebsforschungOTHER | 20 | Oct 23, 2020 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials